Table 2.
Dietary supplement/substance | Preclinical | Phase I | Phase II | Phase III |
---|---|---|---|---|
Copper and penicillamine | X [54–56] | X [57] | ||
Vitamin A/retinoids | X [58] | X [59, 60, 61••] | ||
Vitamin D/vitamin D analogs | X[62] | X [63] | ||
Vitamin C/ascorbic derivatives | X[64] | |||
Curcumin and turmeric | X [66–68] | |||
Boswellic acid/frankincense | X [70] | |||
Selenium | X [73, 74] | X [75] |
Summary of preclinical and clinical (phase I, II, and III) trials conducted for selected dietary supplements